These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17169651)

  • 1. Assessment of American urologists' approach to hormonal management of prostate cancer.
    Warren KS; Osborn J; Chodak GW
    Urology; 2006 Dec; 68(6):1305-7. PubMed ID: 17169651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between urologists in the United States and Canada in the approach to prostate cancer.
    Fleshner N; Rakovitch E; Klotz L
    J Urol; 2000 May; 163(5):1461-6. PubMed ID: 10751858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.
    Milecki P; Kwias Z; Martenka DJ
    Neoplasma; 2007; 54(1):7-15. PubMed ID: 17203887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice trends in the diagnosis and management of prostate cancer in the United States.
    Gee WF; Holtgrewe HL; Albertsen PC; Litwin MS; Manyak MJ; O'Leary MP; Painter MR
    J Urol; 1995 Jul; 154(1):207-8. PubMed ID: 7539862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and management of advanced hormone-refractory prostate cancer: results of a practice survey on 301 French urologists].
    Colombel M; Davin JL; Filleul A; Rousseau C
    Prog Urol; 2004 Apr; 14(2):182-8. PubMed ID: 15217132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese urologists' practice patterns of diagnosing and treating chronic prostatitis: a questionnaire survey.
    Yang J; Liu L; Xie HW; Ginsberg DA
    Urology; 2008 Sep; 72(3):548-51. PubMed ID: 18597833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical malpractice liability in clinical urology: a survey of practicing urologists.
    Sobel DL; Loughlin KR; Coogan CL
    J Urol; 2006 May; 175(5):1847-51. PubMed ID: 16600777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urologists' attitudes regarding cancer clinical research.
    Swanson GP; Carpenter WR; Thompson IM; Crawford ED
    Urology; 2007 Jul; 70(1):19-24. PubMed ID: 17656200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions and competence in evidence-based medicine: a survey of the American Urological Association Membership.
    Dahm P; Poolman RW; Bhandari M; Fesperman SF; Baum J; Kosiak B; Carrick T; Preminger GM;
    J Urol; 2009 Feb; 181(2):767-77. PubMed ID: 19091333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking cessation assistance for patients with bladder cancer: a national survey of American urologists.
    Bjurlin MA; Goble SM; Hollowell CM
    J Urol; 2010 Nov; 184(5):1901-6. PubMed ID: 20846679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of urologists' training and knowledge of energy-based surgical devices.
    Lehman DS; Phillips CK; Hruby GW; Lambert S; Landman J
    BJU Int; 2008 Jul; 102(2):226-30. PubMed ID: 18435809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of consultant decision-making in the management of prostate cancer.
    Wilson J; Kennedy K; Ewings P; Macdonagh R
    Prostate Cancer Prostatic Dis; 2008; 11(3):288-93. PubMed ID: 17968424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trend of managing prostate cancer in Taiwan.
    Wong WY; Chen SC; Chueh SC; Chen J
    Int J Urol; 2004 Jul; 11(7):510-4. PubMed ID: 15242360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based medicine: a survey of American Urological Association members.
    Sur RL; Scales CD; Preminger GM; Dahm P
    J Urol; 2006 Sep; 176(3):1127-34. PubMed ID: 16890708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of non-muscle invasive bladder tumours by instillations of mitomycin C and BCG: a survey on French urologists by the French Urological Association].
    Descazeaud A; Mignard JP; Davin JL; Irani J
    Prog Urol; 2009 Oct; 19(9):624-31. PubMed ID: 19800553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population based study of hormonal therapy and survival in men with metastatic prostate cancer.
    Lu-Yao G; Moore DF; Oleynick JU; DiPaola RS; Yao SL
    J Urol; 2007 Feb; 177(2):535-9. PubMed ID: 17222628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the urologist and nurse from the perspective of patients with prostate cancer receiving luteinizing hormone-releasing hormone analogue therapy.
    Lebret T; Bouregba A
    BJU Int; 2008 Nov; 102(10):1419-24. PubMed ID: 18549431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer.
    Fleshner N; Keane TE; Lawton CA; Mulders PF; Payne H; Taneja SS; Morris T
    Prostate Cancer Prostatic Dis; 2008; 11(1):46-52. PubMed ID: 17607304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.